Wednesday, August 20, 2014. Last Update: Wed 4:04 PM EST

Tags

Big Pharma

Audit Notes: Hiltzik on Drug R&D, A 1 Percent “Score”, Paywalls

The Los Angeles Times's Michael Hiltzik finds a study that questions the drug lobby's line on how much it costs... More

avandia.jpg

Audit Notes: WaPo on Avandia, giving away the store, plutocrats

Report shows how drug research is corrupted by corporate money

The Washington Post's Peter Whoriskey has another outstanding story in his series on the Avandia drug scandal at GlaxoSmithKline and... More

armies.jpg

Big Pharma’s army of messengers

A campaign to kill a drug discount

As we report in a companion piece here on CJR.org--"Medicare uncovered: What's not on the table"--the president's budget proposal,... More

marijn_dekkers.jpg

Bloomberg’s viral misquote

Big Pharma CEO Marijn Dekkers didn’t quite say what they said he did

Last week, Bloomberg News stuffed a jarring quote from Bayer CEO Marijn Dekkers at the bottom of a piece on... More

DrugManufacturing.jpg

Flash: this new drug is not so new

Disappointing coverage of Brisdelle, the hot flash drug, misses a chance to expose one of Big Pharma’s oldest tricks

It seems we are going soft on Pharma these days, if coverage of the FDA marketing clearance of the drug... More

pills.jpg

Journalists’ guide to clinical guidelines

Reporters may get more than they bargain for when they rely on clinical practice guidelines as sources

We may all be in trouble if, as he suggests in a recent New York Times op-ed, Dr. Jerry Avorn... More

oxycontin.jpg

WaPo eyes FDA access-peddling by academics

At $25,000 a pop, a chance for Big Pharma to influence how their drugs would be tested

We write a lot about Wall Street corruption here at The Audit. But if you ask me, Wall Street's got... More

Why The New Yorker’s radical feminism and transgenderism piece was one-sided - “This effectively advances the views of a group that wants to see the genocide of trans women, a group that, data shows, faces extraordinarily high rates of discrimination in every measurable way”

Journalism groups rally around a petition supporting James Risen - The Supreme Court ruled against the NYT reporter, who is refusing to reveal sources

Why one editor won’t run any more op-eds by the Heritage Foundation’s top economist - A reply to Paul Krugman on state taxes and job growth made some incorrect claims

Gannett’s changes bring excitement, some pain, and a full-time beer beat - A conversation with Joshua Awtry, the chain’s top editor in the Carolinas

Build the future - Journalism’s deathwatch is over


Last call (Medium)

“The death of newspapers is sad, but the threatened loss of journalistic talent is catastrophic. If that’s you, it’s time to learn something outside the production routine of your current job.”

Maureen Dowd on James Risen (NYT)

“Risen may be trapped in Ibsen, but Obama is channeling Orwell”

Preparing yourself to cover chaos (Medium)

“There are things you should know before you show up, and you’re not going to find them in the current news cycle”

Journalists can get PTSD right at their desks (PSmag)

A new study correlates exposure to violent images with mental health symptoms

Bloggingheads

Greg Marx discusses democracy and news with Tom Rosenstiel of the American Press Institute

  • If you like the magazine, get the rest of the year for just $19.95 (6 issues in all).
  • If not, simply write cancel on the bill and return it. You will owe nothing.

Who Owns What

The Business of Digital Journalism

A report from the Columbia University Graduate School of Journalism

Study Guides

Questions and exercises for journalism students.